Increasingly , interest is growing within the UK regarding Tesamorelin as a viable therapy for lipodystrophy . While largely recent, knowledge of what it can do – particularly in addressing the consequences of HIV-related fat wasting – is gaining. Doctors are exploring its suitability, and patient demand is growing, suggesting that this therap